Landmark trial looking at test to predict who needs chemotherapy for breast cancer begins

A landmark trial, funded by the NIHR HTA Programme, is looking at a test to predict who needs chemotherapy for breast cancer. The OPTIMA (Optimal Personalised Treatment of breast cancer using Multi-parameter Analysis) trial aims to use genomic tests to identify breast cancer patients who are likely to benefit from chemotherapy and spare those who...
Source: NIHR Evaluation, Trials and Studies News - Category: American Health Source Type: news